Loading clinical trials...

Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis | Clinical Trials | Clareo Health

UNKNOWN

Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis

NCT02987179•Renal Research Institute

View on ClinicalTrials.gov

Summary

The clinical diagnosis of sleep apnea is difficult among ESRD patients since the characteristic clinical features of sleep apnea may be absent and since sleep-related symptoms, such as fatigue and sleepiness, may be attributed to kidney failure. However, the evaluation of patients with possible sleep apnea is the same among ESRD patients as in the general population.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age ≥18 years and able to give written informed consent to the study
•On chronic hemodialysis for ≥ 90 days at time of enrollment
•Ability to read
•Consent to have video recording taken during study visit

Exclusion Criteria

•Subjects with cognitive impairment to consent
•Sickle cell anemia
•Prescription of nasal oxygen
•Simultaneous participation in another clinical trial that may affect breathing frequency/patterns, blood oxygenation, sleep/wake cycle or other parameters related to the outcomes of interest to this study
•Use of a breathing device, e.g. CPAP
•Central venous catheter used as vascular access for hemodialysis
•Artificial fingernails (may disturb the measurement of the WatchPAT)
•Use of one of the following medications: alpha blockers, short acting nitrates (less than 3 hours before the study).
•Permanent pacemaker
•Sustained non-sinus cardiac arrhythmias.

Locations (1)

Renal Research Institute

New York, New York, United States

Key Dates

Start Date

December 1, 2016

Primary Completion Date

March 1, 2017

Completion Date

December 1, 2017

Last Updated

December 8, 2016

Enrollment

ESTIMATED participants

Conditions

ESRDSleep ApneaOxygen Deficiency

Interventions

Observational

OTHER

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

NCT06430957

Obstructive Sleep Apnea Risk ManagementPostoperative Complications+2 more

View study

RECRUITINGNA

Digital-supported Orofacial Myofunctional Therapy in OSA

NCT07292922

Obstructive Sleep Apnea (OSA)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Identification of Desaturation Episodes by Means of Continuous Measurement of Oxygen Saturation During Hemodialysis

Inclusion Criteria

Exclusion Criteria

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

Digital-supported Orofacial Myofunctional Therapy in OSA

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Maxillomandibular Advancement Surgery for Treatment of Obstructive Sleep Apnoea Syndrome

Spanish Registry of Patients With Sleep Apnea and Daytime Sleepiness

A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea